Brainstorm Cell Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Brainstorm Cell Therapeutics Inc.‘s stocks are currently a part of 29 hedge funds’ portfolios, which represents 8.63% of the total amount of its stocks outstanding. This makes up a total of 3.15M shares of Brainstorm Cell Therapeutics Inc.. Compared to the previous quarter, the number fell by -14.73% or -544.39K shares fewer. As for the holding position changes, 27.59% (8) of current hedge fund investors increased the number of shares held, 10.34% (3) of current holders sold a part of the shares held, and 10.34% (3) closed the holdings completely. 7 hedge funds are new holders of Brainstorm Cell Therapeutics Inc. stock in Q1 2023, it is 24.14% of total holders.
Hedge funds holding Brainstorm Cell Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 39 |
|---|---|
| Q3 2018 | 35 |
| Q4 2018 | 35 |
| Q1 2019 | 36 |
| Q2 2019 | 35 |
| Q3 2019 | 37 |
| Q4 2019 | 40 |
| Q1 2020 | 49 |
| Q2 2020 | 76 |
| Q3 2020 | 79 |
| Q4 2020 | 86 |
| Q1 2021 | 71 |
| Q2 2021 | 53 |
| Q3 2021 | 48 |
| Q4 2021 | 40 |
| Q1 2022 | 36 |
| Q2 2022 | 43 |
| Q3 2022 | 38 |
| Q4 2022 | 42 |
| Q1 2023 | 29 |
Hedge funds changes in Brainstorm Cell Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 9 | 14 | 2 | 4 | 10 |
|---|---|---|---|---|---|
| Q3 2018 | 3 | 6 | 5 | 7 | 14 |
| Q4 2018 | 5 | 7 | 2 | 5 | 16 |
| Q1 2019 | 4 | 13 | 4 | 3 | 12 |
| Q2 2019 | 2 | 11 | 5 | 2 | 15 |
| Q3 2019 | 6 | 10 | 5 | 3 | 13 |
| Q4 2019 | 6 | 10 | 10 | 3 | 11 |
| Q1 2020 | 17 | 20 | 1 | 6 | 5 |
| Q2 2020 | 34 | 21 | 12 | 7 | 2 |
| Q3 2020 | 18 | 27 | 15 | 14 | 5 |
| Q4 2020 | 27 | 26 | 19 | 21 | -7 |
| Q1 2021 | 11 | 24 | 23 | 25 | -12 |
| Q2 2021 | 9 | 12 | 25 | 27 | -20 |
| Q3 2021 | 5 | 8 | 25 | 10 | 0 |
| Q4 2021 | 7 | 8 | 12 | 14 | -1 |
| Q1 2022 | 7 | 8 | 9 | 10 | 2 |
| Q2 2022 | 8 | 8 | 15 | 3 | 9 |
| Q3 2022 | 4 | 13 | 9 | 8 | 4 |
| Q4 2022 | 9 | 5 | 11 | 3 | 14 |
| Q1 2023 | 7 | 8 | 3 | 3 | 8 |
Hedge funds changes in Brainstorm Cell Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 212,000 | 0 |
|---|---|---|
| Q3 2018 | 65,000 | 39,000 |
| Q4 2018 | 7,000 | 14,000 |
| Q1 2019 | 62,000 | 1,057,000 |
| Q2 2019 | 7,000 | 2,121,000 |
| Q3 2019 | 107,000 | 2,218,000 |
| Q4 2019 | 244,000 | 1,377,000 |
| Q1 2020 | 3,719,000 | 3,408,000 |
| Q2 2020 | 9,355,000 | 38,281,000 |
| Q3 2020 | 17,641,000 | 37,801,000 |
| Q4 2020 | 4,499,000 | 5,167,000 |
| Q1 2021 | 3,171,000 | 4,872,000 |
| Q2 2021 | 4,230,000 | 4,427,000 |
| Q3 2021 | 3,840,000 | 3,618,000 |
| Q4 2021 | 2,965,000 | 3,869,000 |
| Q1 2022 | 1,674,000 | 698,000 |
| Q2 2022 | 2,446,000 | 308,000 |
| Q3 2022 | 3,651,000 | 435,000 |
| Q4 2022 | 847,351 | 129,964 |
| Q1 2023 | 228,699,000 | 197,721,000 |